Literature DB >> 7764423

Production of purified alginates suitable for use in immunoisolated transplantation.

G Klöck1, H Frank, R Houben, T Zekorn, A Horcher, U Siebers, M Wöhrle, K Federlin, U Zimmermann.   

Abstract

Alginate is used as a matrix for immunoisolation of cells and tissues in vivo. We have demonstrated previously that commercial alginates contain various fractions of mitogenic impurities and that they can be removed by free flow electrophoresis. The use of purified material is a necessity in order to reveal the parameters that control biocompatibility of the implanted material (such as stability, size, surface charge and curvature, etc.). In this study, we present a protocol for the chemical purification of alginates on a large-scale. Beads made from alginates purified by this multi-step chemical extraction procedure did not induce a significant foreign body reaction when implanted for 3 weeks either intraperitoneally or beneath the kidney capsule of Lewis or non-diabetic BB/Gi rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7764423     DOI: 10.1007/BF00173321

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  19 in total

1.  Enzymatic function of alginate immobilized rat hepatocytes.

Authors:  R G Tompkins; E A Carter; J D Carlson; M L Yarmush
Journal:  Biotechnol Bioeng       Date:  1988-01       Impact factor: 4.530

2.  Biocompatibility of wound management products: standardization of and determination of cell growth rate in L929 fibroblast cultures.

Authors:  T D Turner; O Spyratou; R J Schmidt
Journal:  J Pharm Pharmacol       Date:  1989-11       Impact factor: 3.765

3.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

Authors:  M B Hansen; S E Nielsen; K Berg
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Transplantation of encapsulated allogeneic islets into diabetic BB/W rats. Effects of immunosuppression.

Authors:  R Mazaheri; P Atkison; C Stiller; J Dupré; J Vose; G O'Shea
Journal:  Transplantation       Date:  1991-04       Impact factor: 4.939

6.  Induction of cytokine production from human monocytes stimulated with alginate.

Authors:  M Otterlei; K Ostgaard; G Skjåk-Braek; O Smidsrød; P Soon-Shiong; T Espevik
Journal:  J Immunother (1991)       Date:  1991-08

7.  Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets.

Authors:  Z P Lum; I T Tai; M Krestow; J Norton; I Vacek; A M Sun
Journal:  Diabetes       Date:  1991-11       Impact factor: 9.461

8.  The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules.

Authors:  H A Clayton; N J London; P S Colloby; P R Bell; R F James
Journal:  J Microencapsul       Date:  1991 Apr-Jun       Impact factor: 3.142

9.  Stability of alginate-immobilized algal cells.

Authors:  A L Dainty; K H Goulding; P K Robinson; I Simpkins; M D Trevan
Journal:  Biotechnol Bioeng       Date:  1986-02       Impact factor: 4.530

10.  Microencapsulated islets as bioartificial endocrine pancreas.

Authors:  F Lim; A M Sun
Journal:  Science       Date:  1980-11-21       Impact factor: 47.728

View more
  16 in total

1.  Association between macrophage activation and function of micro-encapsulated rat islets.

Authors:  P de Vos; I Smedema; H van Goor; H Moes; J van Zanten; S Netters; L F M de Leij; A de Haan; B J de Haan
Journal:  Diabetologia       Date:  2003-05-15       Impact factor: 10.122

Review 2.  Inorganic nanoporous membranes for immunoisolated cell-based drug delivery.

Authors:  Adam Mendelsohn; Tejal Desai
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 3.  Advances in islet encapsulation technologies.

Authors:  Tejal Desai; Lonnie D Shea
Journal:  Nat Rev Drug Discov       Date:  2016-12-23       Impact factor: 84.694

4.  Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation.

Authors:  G S Korbutt; A G Mallett; Z Ao; M Flashner; R V Rajotte
Journal:  Diabetologia       Date:  2004-10-23       Impact factor: 10.122

5.  Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation.

Authors:  Steven M Jay; Benjamin R Shepherd; James P Bertram; Jordan S Pober; W Mark Saltzman
Journal:  FASEB J       Date:  2008-05-01       Impact factor: 5.191

6.  A study on proliferation and behavior of retinal pigment epithelial cells on purified alginate films.

Authors:  Su Mi Jeong; Eun Young Kim; Ji Hye Hwang; Ga Young Lee; Su Jin Cho; Ji Yeon Bae; Jeong Eun Song; Kun Ho Yoon; Choun-Ki Joo; Dongwon Lee; Gilson Khang
Journal:  Int J Stem Cells       Date:  2011-11       Impact factor: 2.500

7.  A gel-forming poly-L: -guluronic acid produced from no guluronate-rich marine algae using new hydrolysis method: test for endovascular embolization.

Authors:  Hyun Mee Lee; Yeon-Hee Yoon; Woo-Back Lee; Jong-Ki Kim
Journal:  J Mater Sci Mater Med       Date:  2009-04-28       Impact factor: 3.896

8.  Optimization of alginate purification using polyvinylidene difluoride membrane filtration: Effects on immunogenicity and biocompatibility of three-dimensional alginate scaffolds.

Authors:  Hugo P Sondermeijer; Piotr Witkowski; David Woodland; Tetsunori Seki; Frank J Aangenendt; Arnoud van der Laarse; Silviu Itescu; Mark A Hardy
Journal:  J Biomater Appl       Date:  2016-04-25       Impact factor: 2.646

9.  Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking.

Authors:  Steven M Jay; W Mark Saltzman
Journal:  J Control Release       Date:  2008-11-08       Impact factor: 9.776

Review 10.  Materials for diabetes therapeutics.

Authors:  Kaitlin M Bratlie; Roger L York; Michael A Invernale; Robert Langer; Daniel G Anderson
Journal:  Adv Healthc Mater       Date:  2012-04-05       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.